2009

2012

P value

(N = 14)

(N = 17)

Introduction of LADG (n, yes/no/unknown)

5/9/0

12/5/0

0.11

Patients for whom LADG was indicated (n, %)

cMN0

0 (0)

0 (0)

0.98

IA

6 (60.0)

8 (50.0)

IB

3 (30.0)

6 (37.5)

II

1 (10.0)

2 (12.5)

Extent of lymph node dissection in patients undergoing LADG (n, yes/no/unknown)

2/10/2

0/14/3

0.27

Reconstruction in patients undergoing LADG (n, %)

Billroth I

8 (57)

8 (53)

0.97

Billroth I/Roux-en-Y

4 (29)

6 (40)

Billroth I/Billroth II

2 (14)

1 (7)

Duration of LADG surgery (hours), mean ± SD

4.35 ± 0.99

4.05 ± 0.81

0.57

Average length of hospital stay after LADG (day), mean ± SD

12.1 ± 2.25

15.25 ± 2.61

0.03*†

LADG-related increase in the incidence of complications (n, yes/no/unknown)

0/4/10

2/8/7

1.00

Could LADG become a standard treatment in the future? (n, yes/no/unknown)

7/7/0

13/1/3

0.03*‡